MA-0211

MA-0211 · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MA-0211, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort [Phase 1]

See pricing